Dozens of U.S. Hospitals Poised to Defy FDA Directive on COVID Plasma

By JoNel Aleccia, Kaiser Health News Dozens of major hospitals across the U.S. are grappling with whether to ignore a federal decision allowing broader emergency use of blood plasma from recovered COVID patients to treat the disease in favor of dedicating their resources to a gold-standard clinical trial that could help settle the science for good. As many as 45 hospitals from coast to coast have expressed interest in collaborating on a…